SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-23-010884
Filing Date
2023-02-14
Accepted
2023-02-13 17:39:00
Documents
1
Group Members
VIVO OPPORTUNITY, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G ea173384-13ga2vivopanda_aadi.htm SC 13G/A 72743
  Complete submission text file 0001213900-23-010884.txt   74467
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Subject) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83932 | Film No.: 23620328
SIC: 2834 Pharmaceutical Preparations

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 650-688-0818
Vivo Panda, LLC (Filed by) CIK: 0001843847 (see all company filings)

IRS No.: 811777731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A